Lygenesis 2018 Regenerative Medicine Progress Update

Company presentation outlining operational progress on clinical development programs in regenerative medicine, focusing on bioengineered organ implants. Covers advancement in esophageal atresia treatment, expanded scientific leadership, clinical insights from key opinion leaders, and technology optimization with FDA guidance implementation.